William Barry

William Barry

UNVERIFIED PROFILE

Are you William Barry?   Register this Author

Register author
William Barry

William Barry

Publications by authors named "William Barry"

Are you William Barry?   Register this Author

100Publications

2759Reads

17Profile Views

Correction to: Margins in Breast-Conserving Surgery After Neoadjuvant Therapy.

Ann Surg Oncol 2018 12;25(Suppl 3):995

Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6721-1DOI Listing
December 2018

Margins in Breast-Conserving Surgery After Neoadjuvant Therapy.

Ann Surg Oncol 2018 Nov 20;25(12):3541-3547. Epub 2018 Aug 20.

Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1245/s10434-018-6702-4
Publisher Site
http://dx.doi.org/10.1245/s10434-018-6702-4DOI Listing
November 2018

Database Selection and Heterogeneity-More Details, More Credibility-Reply.

JAMA Oncol 2018 Sep;4(9):1295-1296

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.1231DOI Listing
September 2018

Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis.

Eur J Cancer 2018 07 17;97:1-6. Epub 2018 May 17.

Division of New Drug Development, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.03.023DOI Listing
July 2018

Breast cancer-specific survival by age: Worse outcomes for the oldest patients.

Cancer 2018 May 2;124(10):2184-2191. Epub 2018 Mar 2.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935594PMC
May 2018

Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.

Breast Cancer Res Treat 2018 Apr 13;168(3):727-737. Epub 2018 Jan 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4659-4DOI Listing
April 2018

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2018 02 3;36(6):543-553. Epub 2018 Jan 3.

Daniel G. Stover, Ohio State University Comprehensive Cancer Center, Columbus, OH; Heather A. Parsons, Gavin Ha, William T. Barry, Hao Guo, Atish D. Choudhury, Melissa E. Hughes, Deborah A. Dillon, Ann H. Partridge, Nikhil Wagle, Ian E. Krop, Todd R. Golub, Eric P. Winer, Sara M. Tolaney, and Nancy U. Lin, Dana-Farber Cancer Institute; Gad Getz, Massachusetts General Hospital, Boston; Gavin Ha, Samuel S. Freeman, Atish D. Choudhury, Gregory Gydush, Sarah C. Reed, Justin Rhoades, Denisse Rotem, Nikhil Wagle, Gad Getz, Todd R. Golub, and Viktor A. Adalsteinsson, Broad Institute of Harvard and Massachusetts Institute of Technology; and J. Christopher Love, Massachusetts Institute of Technology, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815405PMC
February 2018

Local and Global Cues in the Prosodic Realization of Broad and Narrow Focus in Bulgarian.

Phonetica 2016;73(3-4):256-278. Epub 2017 Feb 23.

Computational Linguistics and Phonetics, Saarland University, Saarbrücken, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000448044DOI Listing
November 2017

Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.

Am J Surg 2017 Oct 28;214(4):687-694. Epub 2017 Jun 28.

Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Dana Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2017.06.017DOI Listing
October 2017

Bayesian response-adaptive designs for basket trials.

Biometrics 2017 09 17;73(3):905-915. Epub 2017 Feb 17.

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/biom.12668DOI Listing
September 2017

Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.

Ann Surg Oncol 2017 Sep 28;24(9):2509-2517. Epub 2017 Apr 28.

Department of Surgery, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5867-6DOI Listing
September 2017

Trial designs and results supporting treatment de-escalation and escalation.

Breast 2017 Aug 30;34 Suppl 1:S10-S12. Epub 2017 Jun 30.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2017.06.020DOI Listing
August 2017

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

Breast Cancer Res Treat 2017 Jul 31;164(1):107-117. Epub 2017 Mar 31.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4222-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479131PMC
July 2017

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.

Ann Surg 2017 03;265(3):581-589

*Harvard School of Public Health, Boston, MA †Department of Surgery, McGill University Health Centre, Montreal, QC, Canada ‡Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA §Department of Surgery, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA ¶Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000001698DOI Listing
March 2017

Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer.

J Natl Compr Canc Netw 2017 03;15(3):316-324

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

View Article

Download full-text PDF

Source
March 2017

Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.

Cancer Invest 2017 Jan 2;35(1):32-35. Epub 2016 Dec 2.

a Division of Medical Oncology, Department of Medicine , Duke University Medical Center , Durham , North Carolina , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2016.1253710DOI Listing
January 2017

Reply to K. Lin et al.

J Clin Oncol 2016 10 25;34(28):3485-6. Epub 2016 Jul 25.

Brigham and Women's Hospital, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.7723DOI Listing
October 2016

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).

J Clin Oncol 2016 08 2;34(22):2602-9. Epub 2016 May 2.

Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.1595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012690PMC
August 2016

Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab.

Breast Cancer Res Treat 2016 08 2;159(1):151-62. Epub 2016 Aug 2.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3927-4DOI Listing
August 2016

Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment.

Oncologist 2016 06 22;21(6):666-70. Epub 2016 Apr 22.

Harvard Medical School, Boston, Massachusetts, USA Dana-Farber Cancer Institute, Boston, Massachusetts, USA Brigham and Women's Hospital, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912366PMC
June 2016

Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.

Breast Cancer Res Treat 2016 06 6;157(3):587-96. Epub 2016 Jun 6.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3845-5DOI Listing
June 2016

Correlation of breast tissue histology and optical signatures to improve margin assessment techniques.

J Biomed Opt 2016 06;21(6):66014

Duke University Medical Center, Department of Pathology, DUMC3712, 200 Trent Drive, Durham, North Carolina 27710, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.JBO.21.6.066014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914603PMC
June 2016

The Drosophila HNF4 nuclear receptor promotes glucose-stimulated insulin secretion and mitochondrial function in adults.

Elife 2016 05 17;5. Epub 2016 May 17.

Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7554/eLife.11183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869932PMC
May 2016

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.

J Clin Oncol 2016 Apr 1;34(11):1190-6. Epub 2016 Feb 1.

Yasuaki Sagara, Melissa Anne Mallory, Fatih Aydogan, and Mehra Golshan, Brigham and Women's Hospital; Yasuaki Sagara, Harvard T.H. Chan School of Public Health; Rachel A. Freedman, Ines Vaz-Luis, Stephen DeSantis, and William T. Barry, Dana-Farber Cancer Institute, Boston, MA; Stephanie M. Wong, McGill University Health Centre, Montreal, Quebec, Canada; and Fatih Aydogan, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872326PMC
April 2016

The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.

Cancer Res 2016 04 3;76(7):1926-34. Epub 2016 Mar 3.

Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-1927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873436PMC
April 2016

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

J Clin Oncol 2016 Feb 2;34(6):542-9. Epub 2015 Nov 2.

Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.1268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980567PMC
February 2016

MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy.

Cancer Discov 2016 Jan 6;6(1):45-58. Epub 2015 Nov 6.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775099PMC
January 2016

Response.

J Natl Cancer Inst 2016 Jan;108(1)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv334DOI Listing
January 2016

The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.

Cancer 2015 Dec 16;121(24):4333-40. Epub 2015 Sep 16.

Department of Surgery, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29687DOI Listing
December 2015

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).

J Natl Cancer Inst 2015 Sep 25;107(9). Epub 2015 Jun 25.

Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/107/9/djv179.full.pdf
Web Search
http://dx.doi.org/10.1093/jnci/djv179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651106PMC
September 2015

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.

JAMA Surg 2015 Aug;150(8):739-45

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2015.0876DOI Listing
August 2015

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

J Clin Oncol 2015 Aug 13;33(24):2623-31. Epub 2015 Jul 13.

Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534525PMC
August 2015

The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies.

J Biopharm Stat 2015 ;25(1):66-88

a Department of Biostatistics and Computational Biology , Dana-Farber Cancer Institute , Boston , Massachusetts , USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.1080/10543406.2014.919
Publisher Site
http://dx.doi.org/10.1080/10543406.2014.919933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459132PMC
July 2015

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).

J Clin Oncol 2015 Jul 8;33(21):2361-9. Epub 2015 Jun 8.

Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.5298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500830PMC
July 2015

Racial differences in outcomes for patients with metastatic breast cancer by disease subtype.

Breast Cancer Res Treat 2015 Jun 29;151(3):697-707. Epub 2015 May 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3432-1DOI Listing
June 2015

Information-seeking and sharing behavior following genomic testing for diabetes risk.

J Genet Couns 2015 Feb 14;24(1):58-66. Epub 2014 Jun 14.

Duke Institute for Genome Sciences & Policy, Duke University, 304 Research Drive, Box 90141, Durham, NC, 27708, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-014-9736-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454388PMC
February 2015

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

N Engl J Med 2015 Jan;372(2):134-41

From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1406281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313867PMC
January 2015

Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.

J Cancer Surviv 2014 Dec 11;8(4):627-37. Epub 2014 Jun 11.

Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-014-0371-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386650PMC
December 2014

Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.

Clin Breast Cancer 2014 Dec 2;14(6):413-6. Epub 2014 Jun 2.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2014.04.007DOI Listing
December 2014

Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance).

J Clin Oncol 2014 Dec 27;32(35):3959-66. Epub 2014 Oct 27.

Harold J. Burstein, William T. Barry, Sara M. Tolaney, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Constance T. Cirrincione, Duke University Alliance Statistics and Data Center; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; Helen K. Chew, University of California, Davis, Davis, CA; Diana E. Lake and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Cynthia Ma, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.7941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251959PMC
December 2014

Familial and sporadic idiopathic pulmonary fibrosis: making the diagnosis from peripheral blood.

BMC Genomics 2014 Oct 16;15:902. Epub 2014 Oct 16.

Division of Allergy, Pulmonary, and Critical Care, Vanderbilt University Medical Center, 1313 21st Avenue South, 1105 Oxford House, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-15-902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288625PMC
October 2014

Making sense of dual HER2-targeting in early breast cancer?

J Natl Cancer Inst 2014 Sep 15;106(9). Epub 2014 Sep 15.

Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC (LAC); Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (WB).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju259DOI Listing
September 2014

Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

J Clin Oncol 2014 Aug 16;32(22):2318-27. Epub 2014 Jun 16.

Vanessa B. Sheppard, Leigh Anne Faul, George Luta, Jonathan D. Clapp, Judy Huei-yu Wang, Claudine Isaacs, Michelle Tallarico, and Jeanne S. Mandelblatt, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Rachel L. Yung and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Gretchen Kimmick, William T. Barry, Brandelyn N. Pitcher, and Harvey J. Cohen, Duke University Medical Center; William T. Barry and Brandelyn N. Pitcher, Cancer and Leukemia Group B Statistical Center, Durham; Hyman B. Muss, University of North Carolina Chapel Hill, Chapel Hill, NC; Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Arti Hurria, City of Hope, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.7367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105485PMC
August 2014

β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers.

Gynecol Oncol 2014 Aug 18;134(2):426-7. Epub 2014 Jun 18.

Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258140104
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2014.06.010DOI Listing
August 2014

Public trust in genomic risk assessment for type 2 diabetes mellitus.

J Genet Couns 2014 Jun 3;23(3):401-8. Epub 2013 Dec 3.

Duke Institute for Genome Sciences & Policy, Duke University, 304 Research Drive, Box 90141, Durham, NC, 27708, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-013-9674-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028379PMC
June 2014

Methods for studying metabolism in Drosophila.

Methods 2014 Jun 12;68(1):105-15. Epub 2014 Mar 12.

Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112-5330, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.indiana.edu/~tennlab/publications/2014_Methods_Te
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S104620231400089
Publisher Site
http://dx.doi.org/10.1016/j.ymeth.2014.02.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048761PMC
June 2014

Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy.

Breast Cancer Res Treat 2014 Jun 23;145(2):491-501. Epub 2014 Apr 23.

Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2968-9DOI Listing
June 2014

Endothelin-1 release during the early phase of reperfusion is a mediator of myocardial reperfusion injury.

Cardiology 2013 29;125(4):242-9. Epub 2013 Jun 29.

Department of Internal Medicine, Division of Cardiology, University of Texas Medical School at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000350655DOI Listing
February 2014

Conformational ordering of biomolecules in the gas phase: nitrogen collision cross sections measured on a prototype high resolution drift tube ion mobility-mass spectrometer.

Anal Chem 2014 Feb 4;86(4):2107-16. Epub 2014 Feb 4.

Department of Chemistry, Vanderbilt Institute of Chemical Biology, Vanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University , Nashville, Tennessee 37235, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ac4038448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931330PMC
February 2014

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.

Gynecol Oncol 2013 Nov 13;131(2):352-6. Epub 2013 Aug 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.08.006DOI Listing
November 2013

Empirical pathway analysis, without permutation.

Biostatistics 2013 Jul 20;14(3):573-85. Epub 2013 Feb 20.

Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/biostatistics/kxt004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677738PMC
July 2013

Public knowledge of and attitudes toward genetics and genetic testing.

Genet Test Mol Biomarkers 2013 Apr 13;17(4):327-35. Epub 2013 Feb 13.

Institute for Genome Sciences and Policy, Duke University, Durham, NC 27708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/gtmb.2012.0350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609633PMC
April 2013

Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy.

Urology 2012 Jul 18;80(1):162-7. Epub 2012 May 18.

Department of Urology, Sant'Andrea Hospital, Second School of Medicine, La Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2012.01.068DOI Listing
July 2012